These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9137133)

  • 1. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder.
    Brawman-Mintzer O; Lydiard RB; Bradwejn J; Villarreal G; Knapp R; Emmanuel N; Ware MR; He Q; Ballenger JC
    Am J Psychiatry; 1997 May; 154(5):700-2. PubMed ID: 9137133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.
    van Megen HJ; Westenberg HG; den Boer JA; Haigh JR; Traub M
    Psychopharmacology (Berl); 1994 Apr; 114(3):449-55. PubMed ID: 7855203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
    Abelson JL; Nesse RM
    Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responses.
    Khan S; Briggs H; Abelson JL
    Psychiatry Res; 2008 Mar; 158(2):141-6. PubMed ID: 18222546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination between panic disorder and generalized anxiety disorder by 35% carbon dioxide challenge.
    Verburg K; Griez E; Meijer J; Pols H
    Am J Psychiatry; 1995 Jul; 152(7):1081-3. PubMed ID: 7793449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls.
    McCann UD; Slate SO; Geraci M; Roscow-Terrill D; Uhde TW
    Neuropsychopharmacology; 1997 Mar; 16(3):229-37. PubMed ID: 9138439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of central administration of the CCK-B receptor agonist pentagastrin on feeding and cortisol release in sheep.
    Ebenezer IS; Parrott RF
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):235-8. PubMed ID: 8803955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers.
    Benkelfat C; Bradwejn J; Meyer E; Ellenbogen M; Milot S; Gjedde A; Evans A
    Am J Psychiatry; 1995 Aug; 152(8):1180-4. PubMed ID: 7625467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology.
    Abelson JL; Nesse RM; Vinik AI
    Biol Psychiatry; 1994 Jul; 36(2):84-96. PubMed ID: 7524696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.
    McCann UD; Morgan CM; Geraci M; Slate SO; Murphy DL; Post RM
    Neuropsychopharmacology; 1997 Dec; 17(6):360-9. PubMed ID: 9397424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiogenic effects of caffeine in patients with anxiety disorders.
    Bruce M; Scott N; Shine P; Lader M
    Arch Gen Psychiatry; 1992 Nov; 49(11):867-9. PubMed ID: 1444724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
    McCann UD; Slate SO; Geraci M; Uhde TW
    Anxiety; 1994-1995; 1(6):258-67. PubMed ID: 9160584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin.
    McManus K; Tait GR; Bellavance F; Le Mellédo JM
    J Affect Disord; 2001 Oct; 66(2-3):273-9. PubMed ID: 11578682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder.
    Le Mellédo J; Jhangri GS; Lott P; Tait GR; McManus K; Geddes M; Chrapko W; Lara N
    Psychiatry Res; 2001 Apr; 101(3):237-42. PubMed ID: 11311926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal.
    Geraci M; Anderson TS; Slate-Cothren S; Post RM; McCann UD
    Biol Psychiatry; 2002 Dec; 52(12):1183-9. PubMed ID: 12488064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of state and trait anxiety on the panic response to CCK-4.
    Eser D; Wenninger S; Baghai T; Schüle C; Rupprecht R
    J Neural Transm (Vienna); 2008 Jun; 115(6):917-20. PubMed ID: 18414777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
    Bradwejn J; Koszycki D; Shriqui C
    Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin.
    Abelson JL; Liberzon I
    Neuropsychopharmacology; 1999 Oct; 21(4):485-94. PubMed ID: 10481831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study.
    Hoehn-Saric R; McLeod DR; Funderburk F; Kowalski P
    Arch Gen Psychiatry; 2004 Sep; 61(9):913-21. PubMed ID: 15351770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.